Trevena, Inc - TRVN Net earnings per one share for the last twelve months

Official company branding of Trevena Inc. (TRVN)

Trevena, Inc. (TRVN) is developing the potential of Olinvyk as an opioid alternative for inpatient settings, which is supported by the annual EPS TTM chart, where 68.80 reflects the baseline level of the metric. The company's environmental vector is based on closed-loop water usage cycles. Operational efficiency is maintained by delegating clinical tests to a network of certified international laboratories.

TRVN: Trevena, Inc. Net earnings per share (EPS TTM) 02/11/2024 - 02/20/2024

trevena.com - analytical breakdowns and key metrics (TRVN)

- share price and expert price forecast:
Initial company analysis:Trevena, TRVN
Product sample of Trevena, Inc.

This indicator measures the dynamics of annual net income per share, reflecting the market's search for the company's fair value. An increase in this metric signals rising profitability, although it requires an analysis of the control premium in the event of a potential acquisition. By analyzing the net income per share YoY ttm growth rate chart, an investor assesses capitalization efficiency. For Trevena, Inc. (TRVN), this metric confirms the commercial success of partnerships with surgical centers. Expanding access to innovative drugs directly impacts the business's bottom-line profitability.

Competitor analysis for Trevena, Inc.

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. HSDT|PASG: Net earnings per share (EPS TTM)|Neuphoria (NEUP) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ADXN (Addex Therapeutics)|Net earnings per share (EPS TTM) Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Net earnings per share for the last 12 months|PTIX (Protagenic Therapeutics) - Earnings per one share for the last 12 months|Pasithea Therapeutics Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Net earnings per share for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CARA|Net earnings per one share for the last twelve months chromocell.com CHRO|Earnings per share for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LBPH (Longboard Pharmaceuticals Inc)|Net earnings per share (EPS TTM) Marinus Pharma MRNS|nkgenbiotech.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Earnings per share for the last twelve months|SNPX - Net earnings per share for the last four quarters|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE